- 1.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789–858. [PubMed][CrossRef]
- 2.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211–59. [PubMed][CrossRef]
- 3.
Bakke Å, Cooper JG, Thue G et al. Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening. BMJ Open Diabetes Res Care 2017; 5: e000459. [PubMed][CrossRef]
- 4.
Ruiz PLD, Stene LC, Bakken IJ et al. Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study. Diabetologia 2018; 61: 2310–8. [PubMed][CrossRef]
- 5.
Carstensen B, Rønn PF, Jørgensen ME. Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996-2016. BMJ Open Diabetes Res Care 2020; 8: e001071. [PubMed][CrossRef]
- 6.
Stene LC, Midthjell K, Jenum AK et al. Hvor mange har diabetes mellitus i Norge? Tidsskr Nor Laegeforen 2004; 124: 1511–4. [PubMed]
- 7.
Brohall G, Behre CJ, Hulthe J et al. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care 2006; 29: 363–7. [PubMed][CrossRef]
- 8.
Selvin E, Crainiceanu CM, Brancati FL et al. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007; 167: 1545–51. [PubMed][CrossRef]
- 9.
Classification of diabetes mellitus. Geneva: World Health Organization; 2019. https://www.who.int/publications/i/item/classification-of-diabetes-mellitus Lest 3.11.2020.
- 10.
Hutchinson MS, Joakimsen RM, Njølstad I et al. Effects of age and sex on estimated diabetes prevalence using different diagnostic criteria: The Tromso OGTT Study. Int J Endocrinol 2013; 2013: 613475. [PubMed][CrossRef]
- 11.
Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011; 34 (Suppl 2): S184–90. [PubMed][CrossRef]
- 12.
Jacobsen BK, Eggen AE, Mathiesen EB et al. Cohort profile: the Tromso Study. Int J Epidemiol 2012; 41: 961–7. [PubMed][CrossRef]
- 13.
Krokstad S, Langhammer A, Hveem K et al. Cohort Profile: the HUNT Study, Norway. Int J Epidemiol 2013; 42: 968–77. [PubMed][CrossRef]
- 14.
Langholz PL, Wilsgaard T, Njølstad I et al. Trends in known and undiagnosed diabetes, HbA1c levels, cardio-metabolic risk factors and diabetes treatment target achievement – The Tromsø Study 1994–2016 medRxiv 2020 doi: 10.1101/2020.10.30.20222117. [CrossRef]
- 15.
Jørgensen ME, Ellervik C, Ekholm O et al. Estimates of prediabetes and undiagnosed type 2 diabetes in Denmark: The end of an epidemic or a diagnostic artefact? Scand J Public Health 2020; 48: 106–12. [PubMed][CrossRef]
- 16.
Fizelova M, Stančáková A, Lorenzo C et al. Glycated hemoglobin levels are mostly dependent on nonglycemic parameters in 9398 Finnish men without diabetes. J Clin Endocrinol Metab 2015; 100: 1989–96. [PubMed][CrossRef]
- 17.
Berge T, Lyngbakken MN, Smith P et al. High prevalence of known and unknown type 2 diabetes mellitus among middle-aged Norwegians: Data from the Akershus cardiac examination (ACE) 1950 study (Abstract). Eur Heart J 2018; 39 (suppl 1): ehy565. [CrossRef]
- 18.
Selvin E, Wang D, Matsushita K et al. Prognostic implications of single-sample confirmatory testing for undiagnosed diabetes: a prospective cohort study. Ann Intern Med 2018; 169: 156–64. [PubMed][CrossRef]
- 19.
Løvaas KF, Madsen TV, Ueland GÅ et al. Norsk diabetesregister for voksne. Data fra diabetespoliklinikker. Diabetes type 1. Årsrapport 2019 med plan for forbedringstiltak. Bergen: Norsk diabetesregister for voksne, 2020. https://www.noklus.no/media/xoah11f2/a-rsrapport-norsk-diabetesregister-for-voksne-2019.pdf Lest 20.10.2020.
- 20.
Skrivarhaug T, Kummernes SJ, Kamaleri Y et al. Årsrapport 2018 med plan for forbedringstiltak. Oslo: Barnediabetesregisteret, 2019. https://oslo-universitetssykehus.no/seksjon-avdeling/Documents/2019.10.01_Endelig_%c3%85rsrapport_2018.pdf Lest 20.10.2020.
- 21.
Folkehelserapporten. Oslo: Folkehelseinstituttet; 2017. https://www.fhi.no/nettpub/hin/ikke-smittsomme/diabetes/ Lest 20.10.2020.
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.
Diabetes i Norge – ulike metoder gir ulike prevalensestimater
02.12.2020Vi leste med interesse kronikken «Hvor mange har diabetes i Norge i 2020?» av Stene og medarbeidere (1). Estimert prevalens av type 2-diabetes basert på informasjon fra Reseptregisteret om bruk av glukosesenkende legemidler og diabetesdiagnoser fra spesialist-…